Explore

Companies
Investors
Funds
Markets
Compare

Capbase

About
FAQ
Data & sources
Contribute

Compare

Crunchbase alternative
PitchBook alternative

Legal

Terms of Service
Privacy Policy
Takedown policy

Koi Biotherapeutics Inc. — Funding, Investors & Profile — Capbase

← All companies

Compare History

Koi Biotherapeutics Inc.

Private

Won a federal SBIR/STTR research award from HHS and other federal agencies.

Department of Health and Human ServicesNational Institutes of Health

SAM UEI: QCVXY1DEA743

Founded: —Source: [GOV]
Headquarters: NEWARK, DelawareSource: [GOV]
Headcount: 2Source: [GOV]
Stage: Seed
Sector: Healthcare

$0Source: [GOV]Total raised

UndisclosedSource: [GOV]Last valuation

Overview

Koi Biotherapeutics Inc. has been awarded 1 US Small Business Innovation Research (SBIR/STTR) contract totalling $1,340,987 in 2025. These are non-dilutive federal research grants, not equity financing. The company is based in NEWARK, Delaware.

Funding rounds

1 rounds

SBIR Phase II award (HHS)GrantAug 2025Source: [GOV]
$1.3M
—post-money

Investors

No investors recorded yet for Koi Biotherapeutics Inc..

Add an investor

People

Leadership

HAMID MAHINIPrincipal investigatorSince 2025Source: [GOV]

Acquisitions

Koi Biotherapeutics Inc. has no recorded acquisitions.

Add an acquisition

Exits

Still private — no exit on record.

Record an exit

Diversity investments

No diversity signals recorded yet for Koi Biotherapeutics Inc..

Add diversity data

Data aggregated from SEC EDGAR, Wikidata, and community contributions. Spotted an error? Propose a change or report an issue.